CorMedix Therapeutics
Developing DefenCath™ to prevent bloodstream infections
- B2B
About CorMedix Therapeutics
Biopharmaceutical company developing and commercializing therapeutic products for infectious and inflammatory diseases, focusing on DefenCath™ to prevent bloodstream infections
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Berkeley Heights, New Jersey, United States
- Founded
- 2006
- Revenue
- $312MFY2025, publicly reported
- Website
- cormedix.com
CorMedix Therapeutics at a glance
CorMedix Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Berkeley Heights, New Jersey, United States.
CorMedix Therapeutics was founded in 2006.
CorMedix Therapeutics has 51–250 employees.
CorMedix Therapeutics's revenue is $312M (FY2025, publicly reported).
Selling to companies like CorMedix Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies